MARIJN E. DEKKERS

Insider Reports History

Location
Boston, MA
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MARIJN E. DEKKERS:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ginkgo Bioworks Holdings, Inc. Director Class A Common Stock 5.52M $3.03M $0.55 12 Jun 2024 By Novalis LifeSciences Investments I, L.P.
Quantum-Si Inc Director Class A Common Stock 500K $885K $1.77 10 Jun 2021 By Novalis Lifesciences Investments I, LP
Quantum-Si Inc Director Class A Common Stock 171K $302K $1.77 11 Jun 2021 Direct
Ginkgo Bioworks Holdings, Inc. Director Class A Common Stock 386K $212K $0.55 12 Jun 2024 Direct
Quanterix Corp Director Common Stock 2.27K $61.1K $26.91 07 Jun 2021 Direct
Cerevel Therapeutics Holdings, Inc. Director Common Stock 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director Common Stock 0 $0 $41.18 01 Aug 2024 Indirect
Ginkgo Bioworks Holdings, Inc. Director Restricted Stock Units 0 $0 $0.55 12 Jun 2024 Direct
Ginkgo Bioworks Holdings, Inc. Director Stock Option 140K 16 Jun 2023 Direct
Quantum-Si Inc Director Stock Option (right to buy) 59.9K 11 May 2022 Direct
Cerevel Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 0 01 Aug 2024 Direct
Quanterix Corp Director Stock Option (Right to Buy) 0 07 Jun 2021 Direct

Insider Reports Filed by MARIJN E. DEKKERS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CERE Cerevel Therapeutics Holdings, Inc. 01 Aug 2024 4 $0 4 Director 05 Aug 2024, 16:28
DNA Ginkgo Bioworks Holdings, Inc. 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 16:22
CERE Cerevel Therapeutics Holdings, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:34
DNA Ginkgo Bioworks Holdings, Inc. 16 May 2024 1 -$220K 4 Director 20 May 2024, 16:54
DNA Ginkgo Bioworks Holdings, Inc. 14 May 2024 1 -$1.61M 4 Director 14 May 2024, 17:13
DNA Ginkgo Bioworks Holdings, Inc. 16 Jun 2023 2 $0 4 Director 21 Jun 2023, 17:04
CERE Cerevel Therapeutics Holdings, Inc. 15 Jun 2023 1 -$6.89M 4 Director 20 Jun 2023, 16:56
CERE Cerevel Therapeutics Holdings, Inc. 07 Jun 2023 2 $0 4 Director 09 Jun 2023, 16:15
CERE Cerevel Therapeutics Holdings, Inc. 31 Dec 2022 1 $0 5 Director 14 Feb 2023, 16:52
DNA Ginkgo Bioworks Holdings, Inc. 03 Nov 2022 1 -$439K 4 Director 07 Nov 2022, 20:34
CERE Cerevel Therapeutics Holdings, Inc. 14 Jun 2022 1 $0 4 Director 16 Jun 2022, 16:46
DNA Ginkgo Bioworks Holdings, Inc. 10 Jun 2022 2 $0 4 Director 13 Jun 2022, 21:17
QSI Quantum-Si Inc 11 May 2022 1 $0 4 Director 13 May 2022, 16:17
DNA Ginkgo Bioworks Holdings, Inc. 11 Mar 2022 1 $0 4 Director 14 Mar 2022, 21:33
CERE Cerevel Therapeutics Holdings, Inc. 24 Sep 2021 2 $0 4 Director 28 Sep 2021, 16:10
DNA Ginkgo Bioworks Holdings, Inc. 16 Sep 2021 2 $0 4 Director 20 Sep 2021, 21:44
DNA Ginkgo Bioworks Holdings, Inc. 16 Sep 2021 0 $0 3 Director 20 Sep 2021, 21:26
CERE Cerevel Therapeutics Holdings, Inc. 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 20:09
QSI Quantum-Si Inc 10 Jun 2021 3 $5M 4 Director 14 Jun 2021, 18:53
QSI Quantum-Si Inc 10 Jun 2021 0 $0 3 Director 14 Jun 2021, 18:38
QTRX Quanterix Corp 11 Jan 2021 9 -$727K 4 Director 08 Jun 2021, 16:19